C12N 2710/20023
Virus like particles [vlp]
Official title: Virus like particles [VLP]
C12N2710/20023 (Virus like particles [vlp]) appears on 170 US grants and 219 published applications in this corpus.
Search patents in C12N- Granted patents
- 170
- Published applications
- 219
- Assignees
- 113
- Inventors
- 344
- Latest grant
- 4 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 7 | 0 |
| 1999 | 7 | 0 |
| 2000 | 5 | 0 |
| 2001 | 4 | 2 |
| 2002 | 9 | 5 |
| 2003 | 5 | 12 |
| 2004 | 2 | 10 |
| 2005 | 6 | 12 |
| 2006 | 4 | 11 |
| 2007 | 13 | 7 |
| 2008 | 11 | 9 |
| 2009 | 7 | 12 |
| 2010 | 9 | 11 |
| 2011 | 6 | 5 |
| 2012 | 3 | 14 |
| 2013 | 1 | 7 |
| 2014 | 3 | 6 |
| 2015 | 4 | 4 |
| 2016 | 6 | 5 |
| 2017 | 9 | 6 |
| 2018 | 4 | 6 |
| 2019 | 5 | 8 |
| 2020 | 7 | 9 |
| 2021 | 5 | 9 |
| 2022 | 6 | 9 |
| 2023 | 4 | 9 |
| 2024 | 7 | 12 |
| 2025 | 4 | 17 |
| 2026 | 5 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Thermostable lipid nanoparticle and methods of use thereof4 Aug 2026US 12,697,308 B2Merck Sharp & Dohme Corp.
- HPV vaccine7 Jul 2026US 12,673,103 B2Merck Sharp & Dohme Corp.
- Contraceptive vaccine based on the sperm-associated protein catsper2 Jun 2026US 12,642,843 B2Rensselaer Polytechnic Institute
- Methods for treating bladder tumors with viral nanoparticle conjugates and immune checkpoint inhibitors31 Mar 2026US 12,589,165 B2Aura Biosciences, Inc.
- Conjugated virus-like particles and uses thereof as anti-tumor immune redirectors20 Jan 2026US 12,528,839 B2Verimmune Inc.
- A Fusion Protein and a Particulate Antigen Containing the Same27 Aug 2026US 2026/0250328 A1Xiamen Innovax Biotech Co., Ltd.
- Switchable mrna expression platform6 Aug 2026US 2026/0224679 A1
- Truncated recombinant l1 protein of human papillomavirus11 Sep 2025US 2025/0281594 A1SK Bioscience Co., Ltd.
- Cytolytic t cell immunotherapy for highly pathogenic coronaviruses4 Sep 2025US 2025/0276056 A1
- Controlled release vaccine formulations26 Jun 2025US 2025/0205328 A1Merck Sharp & Dohme Corp.
Most cited
By later US patents
- Process for purifying human papillomavirus virus-like particles53US 6,602,697 B1Merck & Co., Inc. · 2003
- Chimeric papillomavirus-like particles49US 5,618,536 AThe United States of America as represented by the Department of Health and Human Services · 1997
- Vaccine composition comprising herpes simplex virus and human papilloma virus antigens43US 6,936,255 B1SmithKline Beecham Biologicals s.a. · 2005
- Recombinant papilloma virus L142US 6,013,262 AThe University of Queensland · 2000
- Ichimeric papillomavirus-like particles41US 5,855,891 AThe United States of America as represented by the Department of Health and Human Services · 1999